United Therapeutics Corp. (UTHR) on GreekSoup https://greeksoup.ai/stocks/us/uthr/ Every dated entry in the public record on United Therapeutics Corp.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Fri, 09 Oct 2026 00:00:00 +0000 United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 280 shares at $527.90 on 6 October 2026, $147,813https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-07:4a1650701aWed, 07 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 360 shares at $528.72 on 6 October 2026, $190,339https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-07:2ee707f5afWed, 07 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 240 shares at $530.13 on 6 October 2026, $127,232https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-07:6a3ad86ddbWed, 07 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 320 shares at $531.94 on 6 October 2026, $170,220https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-07:057a3714e5Wed, 07 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 215 shares at $533.14 on 6 October 2026, $114,626https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-07:e1aeeb8a4fWed, 07 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 167 shares at $534.30 on 6 October 2026, $89,228https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-07:6d0e193aaaWed, 07 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 734 shares at $535.71 on 6 October 2026, $393,210https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-07:02e1f7f5cbWed, 07 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 323 shares at $536.25 on 6 October 2026, $173,209https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-07:0e4e48e909Wed, 07 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 133 shares at $537.58 on 6 October 2026, $71,498https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-07:44b9598863Wed, 07 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,088 shares at $538.61 on 6 October 2026, $586,006https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-07:04d1115619Wed, 07 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,606 shares at $539.68 on 6 October 2026, $866,718https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-07:819b61ab52Wed, 07 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 2,054 shares at $540.68 on 6 October 2026, $1.1 millionhttps://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-07:a27f123a44Wed, 07 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 380 shares at $541.55 on 6 October 2026, $205,791https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-07:0c989f8c8aWed, 07 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 120 shares at $542.49 on 6 October 2026, $65,099https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-07:4a427f3b1aWed, 07 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 558 shares at $543.99 on 6 October 2026, $303,548https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-07:7efe3f810fWed, 07 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 842 shares at $544.75 on 6 October 2026, $458,681https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-07:2cd7b69270Wed, 07 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 80 shares at $545.50 on 6 October 2026, $43,640https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-07:f579b7c511Wed, 07 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 501 shares at $536.26 on 5 October 2026, $268,665https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-06:8c6b75a790Tue, 06 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 905 shares at $537.43 on 5 October 2026, $486,373https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-06:a5545a4499Tue, 06 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 655 shares at $538.62 on 5 October 2026, $352,795https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-06:a48b9ac352Tue, 06 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 931 shares at $539.50 on 5 October 2026, $502,279https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-06:2d72047796Tue, 06 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,028 shares at $540.50 on 5 October 2026, $555,633https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-06:21ee1c57baTue, 06 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,239 shares at $541.66 on 5 October 2026, $671,120https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-06:71ce6d5a4eTue, 06 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 918 shares at $542.56 on 5 October 2026, $498,067https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-06:18e2718935Tue, 06 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 783 shares at $543.54 on 5 October 2026, $425,593https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-06:a03236e457Tue, 06 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,260 shares at $544.59 on 5 October 2026, $686,187https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-06:f7179d9689Tue, 06 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 920 shares at $545.69 on 5 October 2026, $502,037https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-06:47df56ac73Tue, 06 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 360 shares at $546.63 on 5 October 2026, $196,788https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-06:ec21df31b1Tue, 06 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 700 shares at $542.06 on 2 October 2026, $379,443https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-05:e60736eba4Mon, 05 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 408 shares at $542.87 on 2 October 2026, $221,492https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-05:db0c52487fMon, 05 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,032 shares at $544.17 on 2 October 2026, $561,588https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-05:bda3b0071aMon, 05 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,280 shares at $544.90 on 2 October 2026, $697,471https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-05:9b70be1b0bMon, 05 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 309 shares at $546.75 on 2 October 2026, $168,945https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-05:5bebf1295dMon, 05 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,171 shares at $547.99 on 2 October 2026, $641,699https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-05:cf10dedab1Mon, 05 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,206 shares at $548.87 on 2 October 2026, $661,943https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-05:643ac052aeMon, 05 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 757 shares at $549.59 on 2 October 2026, $416,040https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-05:b13e7d7b99Mon, 05 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 432 shares at $550.99 on 2 October 2026, $238,027https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-05:f1f0b25e90Mon, 05 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 725 shares at $551.82 on 2 October 2026, $400,067https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-05:ff34aa73f3Mon, 05 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 160 shares at $552.86 on 2 October 2026, $88,457https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-05:711109fb93Mon, 05 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 80 shares at $554.30 on 2 October 2026, $44,344https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-05:d6918a5733Mon, 05 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 80 shares at $555.60 on 2 October 2026, $44,448https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-05:82a27893f9Mon, 05 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 240 shares at $557.43 on 2 October 2026, $133,784https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-05:79f79dbbe9Mon, 05 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 120 shares at $558.60 on 2 October 2026, $67,032https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-05:1d96a2c8f6Mon, 05 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 120 shares at $560.66 on 2 October 2026, $67,279https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-05:e79ca50b6eMon, 05 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 40 shares at $562.35 on 2 October 2026, $22,494https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-05:ae39d95e21Mon, 05 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 80 shares at $563.88 on 2 October 2026, $45,110https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-05:161150e3f7Mon, 05 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 80 shares at $566.58 on 2 October 2026, $45,326https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-05:faeb0950b6Mon, 05 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 240 shares at $569.90 on 2 October 2026, $136,775https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-05:d58cfc14d9Mon, 05 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 120 shares at $570.70 on 2 October 2026, $68,484https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-05:98299582b0Mon, 05 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 80 shares at $572.44 on 2 October 2026, $45,795https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-05:d121cee30aMon, 05 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 40 shares at $574.23 on 2 October 2026, $22,969https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-05:26854a1dd2Mon, 05 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 120 shares at $560.05 on 1 October 2026, $67,206https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-02:c9693ddde1Fri, 02 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 80 shares at $561.68 on 1 October 2026, $44,934https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-02:fc12ff9fa8Fri, 02 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 160 shares at $563.31 on 1 October 2026, $90,130https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-02:72134eb7b2Fri, 02 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 94 shares at $567.90 on 1 October 2026, $53,383https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-02:0ec22c0965Fri, 02 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 306 shares at $569.65 on 1 October 2026, $174,314https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-02:7b62ba9deaFri, 02 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 534 shares at $570.55 on 1 October 2026, $304,673https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-02:6e6b2eb4d5Fri, 02 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 320 shares at $571.52 on 1 October 2026, $182,888https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-02:f53023f419Fri, 02 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 560 shares at $572.86 on 1 October 2026, $320,803https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-02:39ba23f38bFri, 02 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 280 shares at $573.62 on 1 October 2026, $160,615https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-02:c32075f24fFri, 02 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 830 shares at $574.94 on 1 October 2026, $477,204https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-02:d88416f567Fri, 02 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,346 shares at $575.90 on 1 October 2026, $775,165https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-02:1fae9b9b62Fri, 02 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 774 shares at $576.91 on 1 October 2026, $446,525https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-02:373bc24846Fri, 02 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 930 shares at $577.93 on 1 October 2026, $537,477https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-02:5463f2ac87Fri, 02 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 320 shares at $579.02 on 1 October 2026, $185,286https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-02:9d0daff51bFri, 02 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 864 shares at $580.20 on 1 October 2026, $501,291https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-02:838a24673dFri, 02 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 702 shares at $581.21 on 1 October 2026, $408,012https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-02:b33cb3bc8dFri, 02 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 520 shares at $582.24 on 1 October 2026, $302,765https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-02:2e71d93bc1Fri, 02 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 400 shares at $583.28 on 1 October 2026, $233,313https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-02:fc72469362Fri, 02 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 360 shares at $584.66 on 1 October 2026, $210,478https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-02:abc6cff46cFri, 02 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Form 144, PAUL MAHON plans to sell 8,300 shares worth $4.7 million around 1 October 2026https://greeksoup.ai/stocks/us/uthr/planned-sales/us:UTHR:planned-sale:2026-10-01:1f651b98a8Thu, 01 Oct 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Form 144, MARTINE ROTHBLATT plans to sell 209,000 shares worth $113.3 million around 1 October 2026https://greeksoup.ai/stocks/us/uthr/planned-sales/us:UTHR:planned-sale:2026-10-01:c11a652591Thu, 01 Oct 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Mahon Paul A (EVP & GENERAL COUNSEL) sold 880 shares at $558.30 on 1 October 2026, $491,308https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-01:7b404da482Thu, 01 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Mahon Paul A (EVP & GENERAL COUNSEL) sold 1,480 shares at $560.19 on 1 October 2026, $829,083https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-01:ee32cf6c66Thu, 01 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Mahon Paul A (EVP & GENERAL COUNSEL) sold 780 shares at $561.87 on 1 October 2026, $438,259https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-01:193fe2fe74Thu, 01 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Mahon Paul A (EVP & GENERAL COUNSEL) sold 1,480 shares at $563.09 on 1 October 2026, $833,374https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-01:5912310387Thu, 01 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Mahon Paul A (EVP & GENERAL COUNSEL) sold 400 shares at $566.41 on 1 October 2026, $226,562https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-01:91375da5c5Thu, 01 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Mahon Paul A (EVP & GENERAL COUNSEL) sold 720 shares at $567.76 on 1 October 2026, $408,788https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-01:268a0d39ffThu, 01 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Mahon Paul A (EVP & GENERAL COUNSEL) sold 739 shares at $569.15 on 1 October 2026, $420,600https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-01:e3486102cdThu, 01 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Mahon Paul A (EVP & GENERAL COUNSEL) sold 838 shares at $570.90 on 1 October 2026, $478,411https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-01:e947b8d6f6Thu, 01 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Mahon Paul A (EVP & GENERAL COUNSEL) sold 823 shares at $572.25 on 1 October 2026, $470,961https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-01:2a83098c35Thu, 01 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Mahon Paul A (EVP & GENERAL COUNSEL) sold 160 shares at $573.15 on 1 October 2026, $91,704https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-01:18eb55eb82Thu, 01 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 400 shares at $547.29 on 30 September 2026, $218,918https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-01:3dafb1def7Thu, 01 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 280 shares at $548.25 on 30 September 2026, $153,511https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-01:e6bb8ee032Thu, 01 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 240 shares at $549.40 on 30 September 2026, $131,855https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-01:2294a6c4a1Thu, 01 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 400 shares at $550.47 on 30 September 2026, $220,187https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-01:cbdc6dcf98Thu, 01 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 160 shares at $551.50 on 30 September 2026, $88,239https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-01:08f4489e89Thu, 01 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 120 shares at $552.63 on 30 September 2026, $66,315https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-01:9c74ba24dfThu, 01 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 113 shares at $553.78 on 30 September 2026, $62,577https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-01:717ecb9eb5Thu, 01 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 207 shares at $554.70 on 30 September 2026, $114,823https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-01:6414b4876bThu, 01 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 161 shares at $476.14 on 30 September 2026, $76,659https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-01:7c55079ae6Thu, 01 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 749 shares at $477.43 on 30 September 2026, $357,592https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-01:63819eeaccThu, 01 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 650 shares at $478.47 on 30 September 2026, $311,004https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-01:99654edba0Thu, 01 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 359 shares at $479.67 on 30 September 2026, $172,201https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-01:a79461bf7bThu, 01 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 601 shares at $480.79 on 30 September 2026, $288,957https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-01:e3d6538922Thu, 01 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 160 shares at $482.36 on 30 September 2026, $77,177https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-01:c8f55b8d19Thu, 01 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 80 shares at $487.79 on 30 September 2026, $39,023https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-01:cde94be1b6Thu, 01 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 40 shares at $495.32 on 30 September 2026, $19,813https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-01:65b62d6761Thu, 01 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 40 shares at $511.37 on 30 September 2026, $20,455https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-01:baa642153dThu, 01 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 80 shares at $514.90 on 30 September 2026, $41,192https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-01:a8cd33eafbThu, 01 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 80 shares at $517.16 on 30 September 2026, $41,373https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-01:c01203ab3eThu, 01 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 80 shares at $523.36 on 30 September 2026, $41,869https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-01:1629ed2c32Thu, 01 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 80 shares at $524.62 on 30 September 2026, $41,970https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-01:29f7fc258bThu, 01 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 80 shares at $526.09 on 30 September 2026, $42,087https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-01:ae69eef32fThu, 01 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 160 shares at $531.11 on 30 September 2026, $84,978https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-01:86c5dc4e68Thu, 01 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 160 shares at $536.52 on 30 September 2026, $85,843https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-01:213341ba6aThu, 01 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 200 shares at $537.67 on 30 September 2026, $107,534https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-01:06722b6f46Thu, 01 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 40 shares at $538.65 on 30 September 2026, $21,546https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-01:36777b8e3eThu, 01 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 480 shares at $540.78 on 30 September 2026, $259,573https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-01:caf411287aThu, 01 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 580 shares at $541.76 on 30 September 2026, $314,222https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-01:49b034943dThu, 01 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 600 shares at $543.25 on 30 September 2026, $325,947https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-01:2c4f85bbeeThu, 01 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 840 shares at $544.05 on 30 September 2026, $457,000https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-01:442d2545f9Thu, 01 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 920 shares at $545.13 on 30 September 2026, $501,519https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-01:8ccd350350Thu, 01 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 360 shares at $546.23 on 30 September 2026, $196,644https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-10-01:326053d64bThu, 01 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 400 shares at $472.05 on 29 September 2026, $188,818https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-30:e63ee886b3Wed, 30 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 449 shares at $472.97 on 29 September 2026, $212,363https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-30:a8d60070afWed, 30 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 80 shares at $473.86 on 29 September 2026, $37,908https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-30:d1c399607eWed, 30 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 552 shares at $475.12 on 29 September 2026, $262,263https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-30:7ab9166b5fWed, 30 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,395 shares at $476.10 on 29 September 2026, $664,160https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-30:272f14ae17Wed, 30 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 2,135 shares at $477.09 on 29 September 2026, $1.0 millionhttps://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-30:38cb875e62Wed, 30 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 2,309 shares at $478.10 on 29 September 2026, $1.1 millionhttps://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-30:cfabffabb5Wed, 30 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,200 shares at $479.07 on 29 September 2026, $574,889https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-30:65f900f553Wed, 30 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 160 shares at $479.59 on 29 September 2026, $76,734https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-30:e341a7fea1Wed, 30 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 500 shares at $481.22 on 29 September 2026, $240,612https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-30:bba5a1f706Wed, 30 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 120 shares at $482.28 on 29 September 2026, $57,874https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-30:ec23f61287Wed, 30 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 200 shares at $486.77 on 29 September 2026, $97,354https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-30:8784ea6af5Wed, 30 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 280 shares at $472.43 on 28 September 2026, $132,280https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-29:1c6b1e9a14Tue, 29 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 600 shares at $473.28 on 28 September 2026, $283,966https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-29:a9386bc8e4Tue, 29 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 680 shares at $474.46 on 28 September 2026, $322,629https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-29:2edd1b4de9Tue, 29 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 80 shares at $475.28 on 28 September 2026, $38,022https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-29:41b11babfbTue, 29 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 160 shares at $476.68 on 28 September 2026, $76,268https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-29:6f13baf352Tue, 29 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 200 shares at $477.45 on 28 September 2026, $95,490https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-29:5e4b08ab9cTue, 29 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 601 shares at $479.06 on 28 September 2026, $287,913https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-29:122b8b699cTue, 29 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,013 shares at $480.18 on 28 September 2026, $486,427https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-29:a4e83f5272Tue, 29 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,354 shares at $481.20 on 28 September 2026, $651,542https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-29:d96cdf844cTue, 29 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 693 shares at $482.11 on 28 September 2026, $334,104https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-29:4e02c4ba61Tue, 29 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,539 shares at $483.20 on 28 September 2026, $743,648https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-29:712dbe2ec3Tue, 29 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 825 shares at $484.47 on 28 September 2026, $399,685https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-29:b78388b1c9Tue, 29 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,315 shares at $485.45 on 28 September 2026, $638,373https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-29:3f77344887Tue, 29 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 160 shares at $486.00 on 28 September 2026, $77,761https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-29:d3dd3734ceTue, 29 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 40 shares at $470.56 on 25 September 2026, $18,822https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-28:8470991d76Mon, 28 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 200 shares at $471.84 on 25 September 2026, $94,368https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-28:1b08a61b7fMon, 28 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 800 shares at $472.89 on 25 September 2026, $378,309https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-28:1ddddf1542Mon, 28 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 543 shares at $474.15 on 25 September 2026, $257,462https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-28:a26d06b611Mon, 28 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,613 shares at $475.28 on 25 September 2026, $766,623https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-28:3a0d142edfMon, 28 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 2,744 shares at $476.13 on 25 September 2026, $1.3 millionhttps://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-28:50a72f994aMon, 28 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,280 shares at $477.19 on 25 September 2026, $610,805https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-28:4aac8df6ddMon, 28 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,648 shares at $478.18 on 25 September 2026, $788,042https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-28:a980ea08b5Mon, 28 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 632 shares at $478.95 on 25 September 2026, $302,698https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-28:e5289f9e5bMon, 28 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 640 shares at $469.74 on 24 September 2026, $300,631https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-25:4c004eefb2Fri, 25 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 2,603 shares at $470.63 on 24 September 2026, $1.2 millionhttps://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-25:7eedd5787fFri, 25 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 2,160 shares at $471.77 on 24 September 2026, $1.0 millionhttps://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-25:541291b932Fri, 25 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 580 shares at $472.73 on 24 September 2026, $274,184https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-25:9bd721741fFri, 25 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 437 shares at $474.01 on 24 September 2026, $207,141https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-25:d08d8c4f70Fri, 25 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 320 shares at $475.35 on 24 September 2026, $152,114https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-25:e0519dc812Fri, 25 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 280 shares at $476.51 on 24 September 2026, $133,424https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-25:11bb3d001cFri, 25 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 360 shares at $477.58 on 24 September 2026, $171,930https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-25:7eb398c62cFri, 25 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,480 shares at $478.61 on 24 September 2026, $708,337https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-25:682cc66be0Fri, 25 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 600 shares at $479.52 on 24 September 2026, $287,710https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-25:83603d4a11Fri, 25 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 40 shares at $480.33 on 24 September 2026, $19,213https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-25:311d8749a5Fri, 25 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 2,388 shares at $488.70 on 23 September 2026, $1.2 millionhttps://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-24:396e5c6a8fThu, 24 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 2,162 shares at $489.52 on 23 September 2026, $1.1 millionhttps://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-24:c0f6e05168Thu, 24 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,440 shares at $490.48 on 23 September 2026, $706,286https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-24:ec66b03027Thu, 24 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 824 shares at $491.65 on 23 September 2026, $405,124https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-24:4e1d9dce81Thu, 24 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 480 shares at $492.54 on 23 September 2026, $236,421https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-24:fa1a51fbe7Thu, 24 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 160 shares at $493.72 on 23 September 2026, $78,996https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-24:a55549193cThu, 24 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 155 shares at $495.17 on 23 September 2026, $76,752https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-24:68e9ad5f7eThu, 24 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 525 shares at $496.38 on 23 September 2026, $260,598https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-24:3bb9ba9314Thu, 24 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 766 shares at $497.27 on 23 September 2026, $380,908https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-24:ac4694e4ecThu, 24 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 270 shares at $498.38 on 23 September 2026, $134,563https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-24:9cd1e7e871Thu, 24 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 90 shares at $498.90 on 23 September 2026, $44,901https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-24:6dfbe2f90fThu, 24 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 240 shares at $500.05 on 23 September 2026, $120,012https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-24:f7e87e66dfThu, 24 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 240 shares at $489.61 on 22 September 2026, $117,507https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-23:a79cd4b68aWed, 23 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 424 shares at $490.54 on 22 September 2026, $207,988https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-23:1cdb5e773aWed, 23 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 736 shares at $491.45 on 22 September 2026, $361,705https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-23:3280d1e6dbWed, 23 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 628 shares at $492.67 on 22 September 2026, $309,395https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-23:286e8cd881Wed, 23 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,645 shares at $493.70 on 22 September 2026, $812,139https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-23:8a4dd0d0dcWed, 23 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,337 shares at $494.66 on 22 September 2026, $661,358https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-23:3b8bb5ebf2Wed, 23 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,488 shares at $495.77 on 22 September 2026, $737,700https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-23:60cd57b037Wed, 23 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,484 shares at $496.83 on 22 September 2026, $737,295https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-23:240d397fbaWed, 23 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,358 shares at $497.73 on 22 September 2026, $675,912https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-23:94172a846bWed, 23 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 160 shares at $499.07 on 22 September 2026, $79,851https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-23:aa06a5440cWed, 23 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,520 shares at $492.97 on 21 September 2026, $749,321https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-22:7e9d98fa75Tue, 22 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 2,680 shares at $493.60 on 21 September 2026, $1.3 millionhttps://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-22:7a80a21e09Tue, 22 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 2,170 shares at $494.82 on 21 September 2026, $1.1 millionhttps://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-22:06e9f21a50Tue, 22 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 2,287 shares at $495.71 on 21 September 2026, $1.1 millionhttps://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-22:ad0419bfddTue, 22 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 843 shares at $496.62 on 21 September 2026, $418,654https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-22:c1091d2b2eTue, 22 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 248 shares at $492.91 on 18 September 2026, $122,241https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-21:7ca3ea17eeMon, 21 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 2,216 shares at $493.78 on 18 September 2026, $1.1 millionhttps://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-21:4618554abeMon, 21 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 4,269 shares at $494.70 on 18 September 2026, $2.1 millionhttps://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-21:bdc17123f6Mon, 21 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 2,330 shares at $495.66 on 18 September 2026, $1.2 millionhttps://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-21:6718ecd725Mon, 21 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 277 shares at $496.64 on 18 September 2026, $137,569https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-21:6bb8fd7e28Mon, 21 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 160 shares at $498.25 on 18 September 2026, $79,720https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-21:779f11fd11Mon, 21 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 599 shares at $493.22 on 17 September 2026, $295,436https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-18:5398aebfddFri, 18 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,750 shares at $494.34 on 17 September 2026, $865,096https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-18:b34e22ae42Fri, 18 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,905 shares at $495.11 on 17 September 2026, $943,183https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-18:6ee2b944d4Fri, 18 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 2,182 shares at $496.21 on 17 September 2026, $1.1 millionhttps://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-18:6ff589456fFri, 18 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,953 shares at $497.17 on 17 September 2026, $970,978https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-18:d1c02475eaFri, 18 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 151 shares at $497.79 on 17 September 2026, $75,166https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-18:b1741caec3Fri, 18 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 332 shares at $499.10 on 17 September 2026, $165,701https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-18:9b4f6364daFri, 18 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 468 shares at $500.09 on 17 September 2026, $234,043https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-18:fdcf218710Fri, 18 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 160 shares at $501.60 on 17 September 2026, $80,256https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-18:7ce2fb8201Fri, 18 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Mahon Paul A (EVP & GENERAL COUNSEL) sold 1,579 shares at $495.97 on 17 September 2026, $783,132https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-18:9826916fefFri, 18 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Mahon Paul A (EVP & GENERAL COUNSEL) sold 2,873 shares at $496.58 on 17 September 2026, $1.4 millionhttps://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-18:5461989adfFri, 18 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Mahon Paul A (EVP & GENERAL COUNSEL) sold 1,400 shares at $497.54 on 17 September 2026, $696,561https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-18:7290cef762Fri, 18 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Mahon Paul A (EVP & GENERAL COUNSEL) sold 843 shares at $498.74 on 17 September 2026, $420,435https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-18:a97426986fFri, 18 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Mahon Paul A (EVP & GENERAL COUNSEL) sold 1,160 shares at $499.75 on 17 September 2026, $579,712https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-18:9f1e994182Fri, 18 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Mahon Paul A (EVP & GENERAL COUNSEL) sold 125 shares at $500.80 on 17 September 2026, $62,600https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-18:885a30b261Fri, 18 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Mahon Paul A (EVP & GENERAL COUNSEL) sold 320 shares at $501.58 on 17 September 2026, $160,506https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-18:c78f8f7cabFri, 18 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Form 144, PAUL MAHON plans to sell 8,300 shares worth $4.1 million around 17 September 2026https://greeksoup.ai/stocks/us/uthr/planned-sales/us:UTHR:planned-sale:2026-09-17:853ab1214cThu, 17 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 2,080 shares at $498.45 on 16 September 2026, $1.0 millionhttps://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-17:465e05936cThu, 17 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,220 shares at $499.15 on 16 September 2026, $608,966https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-17:bd95fa35f6Thu, 17 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 492 shares at $500.19 on 16 September 2026, $246,096https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-17:16ccbbd848Thu, 17 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 708 shares at $501.52 on 16 September 2026, $355,077https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-17:5bbefd62f6Thu, 17 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 2,160 shares at $502.44 on 16 September 2026, $1.1 millionhttps://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-17:4af655f172Thu, 17 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,538 shares at $503.53 on 16 September 2026, $774,429https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-17:ad8ad57d73Thu, 17 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,182 shares at $504.17 on 16 September 2026, $595,932https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-17:1ee314a214Thu, 17 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 120 shares at $505.20 on 16 September 2026, $60,624https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-17:600607d90fThu, 17 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 780 shares at $499.77 on 15 September 2026, $389,824https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-16:700b955a7eWed, 16 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 3,711 shares at $500.68 on 15 September 2026, $1.9 millionhttps://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-16:fbb02903d2Wed, 16 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 2,689 shares at $501.66 on 15 September 2026, $1.3 millionhttps://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-16:1b8e4fff8dWed, 16 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 825 shares at $502.57 on 15 September 2026, $414,620https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-16:fc0881b056Wed, 16 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 845 shares at $503.80 on 15 September 2026, $425,715https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-16:f7e5cf7b73Wed, 16 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 650 shares at $504.57 on 15 September 2026, $327,971https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-16:39cca8c106Wed, 16 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,580 shares at $502.15 on 14 September 2026, $793,399https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-15:86d1e68e7fTue, 15 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 2,358 shares at $503.44 on 14 September 2026, $1.2 millionhttps://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-15:654d19f03cTue, 15 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 2,722 shares at $504.47 on 14 September 2026, $1.4 millionhttps://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-15:ef806d6f40Tue, 15 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 2,400 shares at $505.25 on 14 September 2026, $1.2 millionhttps://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-15:5efd554accTue, 15 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 440 shares at $506.48 on 14 September 2026, $222,851https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-15:41df3555aaTue, 15 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Mesa Nilda (Director) sold 130 shares at $505.79 on 14 September 2026, $65,752https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-15:e52861b0f8Tue, 15 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Mesa Nilda (Director) sold 98 shares at $505.98 on 14 September 2026, $49,586https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-15:6480b8ca8fTue, 15 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: short interest 2,800,470 shares at the 15 September 2026 settlement, 3.90 days to coverhttps://greeksoup.ai/stocks/us/uthr/short-interest/us:UTHR:short-interest:2026-09-15:6983758404Tue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Form 144, NILDA MESA plans to sell 228 shares worth $115,338 around 14 September 2026https://greeksoup.ai/stocks/us/uthr/planned-sales/us:UTHR:planned-sale:2026-09-14:d3bb339c25Mon, 14 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,341 shares at $496.74 on 11 September 2026, $666,126https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-14:83536e8ee9Mon, 14 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 2,138 shares at $497.99 on 11 September 2026, $1.1 millionhttps://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-14:c4aa627db9Mon, 14 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,021 shares at $498.97 on 11 September 2026, $509,446https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-14:3ebd6df0e1Mon, 14 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 204 shares at $499.61 on 11 September 2026, $101,921https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-14:179dbbaef7Mon, 14 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 476 shares at $500.86 on 11 September 2026, $238,409https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-14:a8118fc3c7Mon, 14 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,560 shares at $502.13 on 11 September 2026, $783,323https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-14:292ef2d9c2Mon, 14 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 850 shares at $503.10 on 11 September 2026, $427,634https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-14:2443f0b197Mon, 14 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 710 shares at $503.99 on 11 September 2026, $357,835https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-14:57c99a1538Mon, 14 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 82 shares at $504.97 on 11 September 2026, $41,407https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-14:ca99dce483Mon, 14 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 518 shares at $506.44 on 11 September 2026, $262,336https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-14:963f25bc26Mon, 14 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 320 shares at $507.31 on 11 September 2026, $162,338https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-14:a79e891b07Mon, 14 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 280 shares at $508.21 on 11 September 2026, $142,299https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-14:a701cc57d0Mon, 14 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 120 shares at $498.44 on 10 September 2026, $59,813https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-11:242ce501baFri, 11 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,788 shares at $499.75 on 10 September 2026, $893,548https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-11:e2f88b3290Fri, 11 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,372 shares at $500.58 on 10 September 2026, $686,797https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-11:bf698b4babFri, 11 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 2,244 shares at $501.88 on 10 September 2026, $1.1 millionhttps://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-11:c567da8eb1Fri, 11 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,536 shares at $502.80 on 10 September 2026, $772,300https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-11:2ea13a358bFri, 11 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 578 shares at $503.76 on 10 September 2026, $291,174https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-11:e3505a7efcFri, 11 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 702 shares at $505.03 on 10 September 2026, $354,533https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-11:c5351d809aFri, 11 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 600 shares at $505.94 on 10 September 2026, $303,564https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-11:97d2884b3cFri, 11 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 280 shares at $506.76 on 10 September 2026, $141,893https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-11:341a0e111cFri, 11 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 280 shares at $508.80 on 10 September 2026, $142,465https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-11:8119abb890Fri, 11 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 80 shares at $493.81 on 9 September 2026, $39,504https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-10:9b7d95f597Thu, 10 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,202 shares at $495.65 on 9 September 2026, $595,775https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-10:3487c1c79dThu, 10 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,278 shares at $496.73 on 9 September 2026, $634,817https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-10:5545d6e1b2Thu, 10 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 160 shares at $497.56 on 9 September 2026, $79,609https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-10:6a01dd94a2Thu, 10 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 400 shares at $498.85 on 9 September 2026, $199,539https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-10:7a45dec5dcThu, 10 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 519 shares at $499.73 on 9 September 2026, $259,362https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-10:95985b31a4Thu, 10 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 361 shares at $500.84 on 9 September 2026, $180,803https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-10:d4c7dcc3e8Thu, 10 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,017 shares at $502.87 on 9 September 2026, $511,414https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-10:15fe4b8bb3Thu, 10 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,144 shares at $503.60 on 9 September 2026, $576,123https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-10:2d8e20d039Thu, 10 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 964 shares at $505.03 on 9 September 2026, $486,847https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-10:24512af206Thu, 10 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 875 shares at $505.78 on 9 September 2026, $442,560https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-10:c08decf735Thu, 10 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 794 shares at $506.84 on 9 September 2026, $402,429https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-10:a3394e72a3Thu, 10 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 506 shares at $507.68 on 9 September 2026, $256,885https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-10:e699a6dd29Thu, 10 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 200 shares at $509.00 on 9 September 2026, $101,800https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-10:e9ac5da0d1Thu, 10 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 40 shares at $481.91 on 8 September 2026, $19,276https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-09:0b91985837Wed, 09 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 200 shares at $483.90 on 8 September 2026, $96,780https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-09:18b39e62bdWed, 09 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 220 shares at $491.04 on 8 September 2026, $108,028https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-09:50b1da5fd1Wed, 09 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 140 shares at $492.72 on 8 September 2026, $68,980https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-09:3d05ab53c5Wed, 09 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 144 shares at $493.98 on 8 September 2026, $71,133https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-09:83f5f3a2bcWed, 09 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 600 shares at $494.87 on 8 September 2026, $296,923https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-09:a13f4980e9Wed, 09 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 256 shares at $495.75 on 8 September 2026, $126,912https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-09:c9a759dfc1Wed, 09 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 300 shares at $497.05 on 8 September 2026, $149,115https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-09:572fd5a94bWed, 09 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,902 shares at $498.18 on 8 September 2026, $947,531https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-09:90dcf9bde7Wed, 09 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,018 shares at $498.77 on 8 September 2026, $507,746https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-09:c5f2b510bbWed, 09 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,173 shares at $500.20 on 8 September 2026, $586,734https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-09:8a6e21782bWed, 09 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,221 shares at $501.17 on 8 September 2026, $611,934https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-09:b33ea79ea5Wed, 09 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,167 shares at $502.26 on 8 September 2026, $586,135https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-09:0608f7d192Wed, 09 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 701 shares at $503.33 on 8 September 2026, $352,833https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-09:b32bdadac1Wed, 09 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 418 shares at $504.15 on 8 September 2026, $210,733https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-09:908049b2faWed, 09 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp. filed 8-K: material agreement, regulation fd disclosurehttps://greeksoup.ai/stocks/us/uthr/filings/us:UTHR:filing:2026-09-08:c3909c9722Tue, 08 Sep 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 40 shares at $485.85 on 4 September 2026, $19,434https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-08:099d12eec1Tue, 08 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 223 shares at $486.88 on 4 September 2026, $108,574https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-08:9aee8e7dd2Tue, 08 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 2,818 shares at $488.08 on 4 September 2026, $1.4 millionhttps://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-08:e44d5482bfTue, 08 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 3,425 shares at $489.12 on 4 September 2026, $1.7 millionhttps://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-08:c71632dafeTue, 08 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,514 shares at $490.01 on 4 September 2026, $741,874https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-08:11fa779b39Tue, 08 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,160 shares at $490.94 on 4 September 2026, $569,485https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-08:ae9e090548Tue, 08 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 320 shares at $491.69 on 4 September 2026, $157,342https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-08:382fe932d0Tue, 08 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 200 shares at $479.07 on 3 September 2026, $95,813https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-04:f1bfdae359Fri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 440 shares at $480.53 on 3 September 2026, $211,431https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-04:99cb42442aFri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 600 shares at $481.47 on 3 September 2026, $288,884https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-04:fb135656e3Fri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 400 shares at $482.35 on 3 September 2026, $192,938https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-04:3fcb8bef89Fri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 80 shares at $483.69 on 3 September 2026, $38,695https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-04:a5642a27d2Fri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 240 shares at $485.16 on 3 September 2026, $116,438https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-04:c1185786ccFri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 411 shares at $486.72 on 3 September 2026, $200,044https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-04:13ca32a047Fri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,429 shares at $487.87 on 3 September 2026, $697,160https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-04:8ef5e9136eFri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,604 shares at $488.68 on 3 September 2026, $783,847https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-04:503fde0f73Fri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 3,114 shares at $489.62 on 3 September 2026, $1.5 millionhttps://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-04:85470f1a65Fri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 940 shares at $490.50 on 3 September 2026, $461,070https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-04:8b16021738Fri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 42 shares at $491.25 on 3 September 2026, $20,632https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-04:274945e97bFri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Form 144, PAUL MAHON plans to sell 8,300 shares worth $4.0 million around 3 September 2026https://greeksoup.ai/stocks/us/uthr/planned-sales/us:UTHR:planned-sale:2026-09-03:d6fa17b727Thu, 03 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Mahon Paul A (EVP & GENERAL COUNSEL) sold 1,545 shares at $478.93 on 3 September 2026, $739,954https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-03:dc662fc3d3Thu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Mahon Paul A (EVP & GENERAL COUNSEL) sold 936 shares at $479.66 on 3 September 2026, $448,959https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-03:7519bb13feThu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Mahon Paul A (EVP & GENERAL COUNSEL) sold 2,360 shares at $480.86 on 3 September 2026, $1.1 millionhttps://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-03:8e9d40ad30Thu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Mahon Paul A (EVP & GENERAL COUNSEL) sold 1,048 shares at $481.92 on 3 September 2026, $505,049https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-03:7927c4a2e8Thu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Mahon Paul A (EVP & GENERAL COUNSEL) sold 160 shares at $482.66 on 3 September 2026, $77,226https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-03:9bad7626cfThu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Mahon Paul A (EVP & GENERAL COUNSEL) sold 200 shares at $483.85 on 3 September 2026, $96,770https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-03:90ea49c1e9Thu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Mahon Paul A (EVP & GENERAL COUNSEL) sold 954 shares at $485.12 on 3 September 2026, $462,807https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-03:3f6e141fd5Thu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Mahon Paul A (EVP & GENERAL COUNSEL) sold 598 shares at $486.47 on 3 September 2026, $290,908https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-03:d36f15b9a4Thu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Mahon Paul A (EVP & GENERAL COUNSEL) sold 169 shares at $487.36 on 3 September 2026, $82,364https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-03:48bf5952b1Thu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Mahon Paul A (EVP & GENERAL COUNSEL) sold 10 shares at $488.32 on 3 September 2026, $4,883https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-03:1a5b9e0c74Thu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Mahon Paul A (EVP & GENERAL COUNSEL) sold 320 shares at $490.88 on 3 September 2026, $157,083https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-03:39fa7a29beThu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 120 shares at $477.70 on 2 September 2026, $57,324https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-03:6bf0a0702dThu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 160 shares at $478.85 on 2 September 2026, $76,616https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-03:5115afaa6cThu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 160 shares at $479.89 on 2 September 2026, $76,782https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-03:dff30eb7cfThu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 80 shares at $482.61 on 2 September 2026, $38,609https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-03:b954ac6de4Thu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 120 shares at $485.12 on 2 September 2026, $58,215https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-03:da783e9a34Thu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 160 shares at $486.32 on 2 September 2026, $77,811https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-03:4e029b60c8Thu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 240 shares at $489.06 on 2 September 2026, $117,373https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-03:6e2fe23a55Thu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 560 shares at $490.19 on 2 September 2026, $274,507https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-03:2ff7bc42e6Thu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,833 shares at $491.38 on 2 September 2026, $900,704https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-03:5406ad4371Thu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 2,067 shares at $492.25 on 2 September 2026, $1.0 millionhttps://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-03:5d7e7f872eThu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 520 shares at $493.59 on 2 September 2026, $256,668https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-03:1b332153aaThu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 520 shares at $494.33 on 2 September 2026, $257,051https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-03:0bfd0cfc2eThu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 423 shares at $495.95 on 2 September 2026, $209,789https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-03:7540c62940Thu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 777 shares at $496.95 on 2 September 2026, $386,128https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-03:b212381659Thu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 364 shares at $498.21 on 2 September 2026, $181,347https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-03:de341d3394Thu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 542 shares at $498.97 on 2 September 2026, $270,443https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-03:7e8b4bb5aeThu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 54 shares at $500.22 on 2 September 2026, $27,012https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-03:72c2fbc653Thu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 160 shares at $501.06 on 2 September 2026, $80,170https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-03:7e26a68483Thu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 120 shares at $502.01 on 2 September 2026, $60,241https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-03:2b91507b8dThu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 200 shares at $504.15 on 2 September 2026, $100,830https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-03:2e40a68ce2Thu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 40 shares at $505.20 on 2 September 2026, $20,208https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-03:f0e254b5fcThu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 40 shares at $506.27 on 2 September 2026, $20,251https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-03:5eedc98775Thu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 80 shares at $508.36 on 2 September 2026, $40,669https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-03:99f519743dThu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 160 shares at $510.05 on 2 September 2026, $81,608https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-03:0cf3a24f2aThu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 320 shares at $510.72 on 1 September 2026, $163,432https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-02:b8d368b794Wed, 02 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 825 shares at $511.95 on 1 September 2026, $422,359https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-02:c6fb0b004bWed, 02 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,732 shares at $513.12 on 1 September 2026, $888,721https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-02:1a5d0d2803Wed, 02 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 3,454 shares at $514.09 on 1 September 2026, $1.8 millionhttps://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-02:6eed0367b3Wed, 02 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,620 shares at $514.98 on 1 September 2026, $834,272https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-02:14547365c8Wed, 02 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,469 shares at $516.03 on 1 September 2026, $758,049https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-02:588dfbbd8aWed, 02 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 80 shares at $516.62 on 1 September 2026, $41,330https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-02:b989cf03efWed, 02 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Form 144, MARTINE ROTHBLATT plans to sell 199,500 shares worth $101.8 million around 1 September 2026https://greeksoup.ai/stocks/us/uthr/planned-sales/us:UTHR:planned-sale:2026-09-01:47a1b6fc64Tue, 01 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 599 shares at $507.84 on 31 August 2026, $304,198https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-01:2381756ca6Tue, 01 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 794 shares at $508.92 on 31 August 2026, $404,082https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-01:74f9ff9a15Tue, 01 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 810 shares at $509.84 on 31 August 2026, $412,967https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-01:d7475eccf7Tue, 01 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 4,217 shares at $510.93 on 31 August 2026, $2.2 millionhttps://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-01:3646c7cdebTue, 01 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,600 shares at $511.75 on 31 August 2026, $818,801https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-01:a9ad503ac2Tue, 01 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 678 shares at $513.50 on 31 August 2026, $348,154https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-01:eefc758335Tue, 01 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 762 shares at $514.32 on 31 August 2026, $391,913https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-01:2206ae28b0Tue, 01 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 40 shares at $514.96 on 31 August 2026, $20,598https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-09-01:62fc8551e2Tue, 01 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 480 shares at $514.26 on 28 August 2026, $246,843https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-31:4bb1c25029Mon, 31 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,630 shares at $515.46 on 28 August 2026, $840,198https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-31:1364c73cf2Mon, 31 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 2,386 shares at $516.16 on 28 August 2026, $1.2 millionhttps://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-31:72e6a5362aMon, 31 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,486 shares at $517.11 on 28 August 2026, $768,421https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-31:c2d116c279Mon, 31 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,346 shares at $518.14 on 28 August 2026, $697,421https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-31:21f0e0053fMon, 31 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 412 shares at $519.19 on 28 August 2026, $213,907https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-31:574e492cafMon, 31 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 751 shares at $520.30 on 28 August 2026, $390,743https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-31:65349aed3dMon, 31 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 286 shares at $521.58 on 28 August 2026, $149,172https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-31:a336c94db9Mon, 31 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 517 shares at $522.40 on 28 August 2026, $270,082https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-31:0c3df24e45Mon, 31 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 6 shares at $523.42 on 28 August 2026, $3,141https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-31:aa12a1a7d3Mon, 31 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 200 shares at $524.42 on 28 August 2026, $104,884https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-31:9f4cb00e30Mon, 31 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: short interest 2,059,685 shares at the 31 August 2026 settlement, 4.81 days to coverhttps://greeksoup.ai/stocks/us/uthr/short-interest/us:UTHR:short-interest:2026-08-31:fed288ce2aMon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 494 shares at $511.58 on 27 August 2026, $252,718https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-28:c80c11d427Fri, 28 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 642 shares at $512.47 on 27 August 2026, $329,007https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-28:6c08b32576Fri, 28 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 704 shares at $513.40 on 27 August 2026, $361,434https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-28:de400de260Fri, 28 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 120 shares at $514.32 on 27 August 2026, $61,718https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-28:e30074f329Fri, 28 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 240 shares at $515.33 on 27 August 2026, $123,679https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-28:69b286cfeaFri, 28 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 280 shares at $517.07 on 27 August 2026, $144,780https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-28:64f972e10dFri, 28 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 200 shares at $518.89 on 27 August 2026, $103,779https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-28:646b5d9224Fri, 28 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,003 shares at $520.23 on 27 August 2026, $521,795https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-28:54e5f87854Fri, 28 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 477 shares at $521.24 on 27 August 2026, $248,629https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-28:fe5d514d37Fri, 28 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 280 shares at $522.40 on 27 August 2026, $146,273https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-28:58a6cf26e6Fri, 28 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 240 shares at $523.60 on 27 August 2026, $125,664https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-28:5f45a2eef2Fri, 28 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 744 shares at $524.61 on 27 August 2026, $390,310https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-28:014925aaecFri, 28 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 376 shares at $525.62 on 27 August 2026, $197,632https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-28:74c530a594Fri, 28 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 280 shares at $526.37 on 27 August 2026, $147,385https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-28:21dd60c821Fri, 28 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,237 shares at $528.29 on 27 August 2026, $653,500https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-28:c01d89c85fFri, 28 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,308 shares at $529.15 on 27 August 2026, $692,128https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-28:08732b30c2Fri, 28 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 755 shares at $530.08 on 27 August 2026, $400,210https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-28:e9a1a95181Fri, 28 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 120 shares at $531.12 on 27 August 2026, $63,734https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-28:aaf6c0fa68Fri, 28 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 559 shares at $514.64 on 26 August 2026, $287,682https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-27:3234689b7fThu, 27 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,591 shares at $515.41 on 26 August 2026, $820,010https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-27:1348e42fb4Thu, 27 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,128 shares at $516.70 on 26 August 2026, $582,832https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-27:5ce494dfb3Thu, 27 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 3,516 shares at $517.49 on 26 August 2026, $1.8 millionhttps://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-27:ac6494cb3bThu, 27 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,790 shares at $518.35 on 26 August 2026, $927,846https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-27:5b315165b2Thu, 27 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 476 shares at $519.35 on 26 August 2026, $247,211https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-27:854ca14ce2Thu, 27 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 400 shares at $520.62 on 26 August 2026, $208,247https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-27:840b8ddfe8Thu, 27 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 40 shares at $521.48 on 26 August 2026, $20,859https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-27:8ea3bdd2e2Thu, 27 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 2,029 shares at $516.12 on 25 August 2026, $1.0 millionhttps://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-26:235f0a06cbWed, 26 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 2,332 shares at $516.95 on 25 August 2026, $1.2 millionhttps://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-26:19170d1243Wed, 26 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 2,004 shares at $518.08 on 25 August 2026, $1.0 millionhttps://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-26:62330495e7Wed, 26 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 2,387 shares at $518.80 on 25 August 2026, $1.2 millionhttps://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-26:21bea2cf32Wed, 26 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 668 shares at $519.91 on 25 August 2026, $347,297https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-26:a76c0153b3Wed, 26 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 80 shares at $520.50 on 25 August 2026, $41,640https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-26:c7be6bd720Wed, 26 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 224 shares at $509.41 on 24 August 2026, $114,108https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-25:9282e33fcfTue, 25 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,323 shares at $510.52 on 24 August 2026, $675,421https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-25:e841500557Tue, 25 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 3,056 shares at $511.63 on 24 August 2026, $1.6 millionhttps://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-25:7cbad9abc1Tue, 25 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 3,592 shares at $512.46 on 24 August 2026, $1.8 millionhttps://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-25:6b31febbd8Tue, 25 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,305 shares at $513.35 on 24 August 2026, $669,921https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-25:0434fcd2cdTue, 25 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,189 shares at $512.71 on 21 August 2026, $609,617https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-24:a9b6eb1947Mon, 24 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 271 shares at $513.85 on 21 August 2026, $139,254https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-24:cff797b4e9Mon, 24 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 624 shares at $515.26 on 21 August 2026, $321,524https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-24:1072e89111Mon, 24 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,689 shares at $516.15 on 21 August 2026, $871,777https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-24:f200e44cfdMon, 24 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 773 shares at $517.07 on 21 August 2026, $399,695https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-24:e69ab83774Mon, 24 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,077 shares at $518.14 on 21 August 2026, $558,032https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-24:1d4528900bMon, 24 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 837 shares at $519.09 on 21 August 2026, $434,474https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-24:055ac0aa79Mon, 24 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 440 shares at $520.03 on 21 August 2026, $228,814https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-24:362cdb60d3Mon, 24 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 371 shares at $521.28 on 21 August 2026, $193,395https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-24:030541215fMon, 24 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 669 shares at $522.29 on 21 August 2026, $349,411https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-24:bf5e15d9bfMon, 24 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 455 shares at $523.62 on 21 August 2026, $238,247https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-24:a4eb54186bMon, 24 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 625 shares at $524.35 on 21 August 2026, $327,720https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-24:f2e9d70434Mon, 24 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 235 shares at $525.42 on 21 August 2026, $123,474https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-24:3bb149e2fcMon, 24 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 45 shares at $526.47 on 21 August 2026, $23,691https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-24:64248c3908Mon, 24 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 200 shares at $527.71 on 21 August 2026, $105,542https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-24:7a3d135063Mon, 24 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 976 shares at $518.45 on 20 August 2026, $506,006https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-21:177f88ee59Fri, 21 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,504 shares at $519.51 on 20 August 2026, $781,344https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-21:7244574b0aFri, 21 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 2,357 shares at $520.46 on 20 August 2026, $1.2 millionhttps://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-21:ce4e66c08aFri, 21 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 2,470 shares at $521.39 on 20 August 2026, $1.3 millionhttps://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-21:5110e54a48Fri, 21 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 960 shares at $522.37 on 20 August 2026, $501,477https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-21:3660db683cFri, 21 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 800 shares at $523.26 on 20 August 2026, $418,607https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-21:0b46669192Fri, 21 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 240 shares at $525.10 on 20 August 2026, $126,023https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-21:f0d5323530Fri, 21 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 193 shares at $526.97 on 20 August 2026, $101,705https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-21:a822bbba19Fri, 21 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Mahon Paul A (EVP & GENERAL COUNSEL) sold 2,690 shares at $524.15 on 20 August 2026, $1.4 millionhttps://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-21:4792925c98Fri, 21 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Mahon Paul A (EVP & GENERAL COUNSEL) sold 502 shares at $520.03 on 20 August 2026, $261,057https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-21:066166eb7bFri, 21 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Mahon Paul A (EVP & GENERAL COUNSEL) sold 1,819 shares at $521.04 on 20 August 2026, $947,773https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-21:163fdcd741Fri, 21 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Mahon Paul A (EVP & GENERAL COUNSEL) sold 787 shares at $522.00 on 20 August 2026, $410,817https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-21:0e426bb301Fri, 21 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Mahon Paul A (EVP & GENERAL COUNSEL) sold 850 shares at $522.78 on 20 August 2026, $444,366https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-21:166d2a10c6Fri, 21 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Mahon Paul A (EVP & GENERAL COUNSEL) sold 192 shares at $523.69 on 20 August 2026, $100,548https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-21:5c2044be73Fri, 21 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Mahon Paul A (EVP & GENERAL COUNSEL) sold 940 shares at $525.25 on 20 August 2026, $493,735https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-21:bf758f1db7Fri, 21 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Mahon Paul A (EVP & GENERAL COUNSEL) sold 400 shares at $526.38 on 20 August 2026, $210,554https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-21:313f468f9eFri, 21 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Mahon Paul A (EVP & GENERAL COUNSEL) sold 120 shares at $527.21 on 20 August 2026, $63,265https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-21:2748e3466cFri, 21 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Form 144, PAUL MAHON plans to sell 8,300 shares worth $4.3 million around 20 August 2026https://greeksoup.ai/stocks/us/uthr/planned-sales/us:UTHR:planned-sale:2026-08-20:d73955e273Thu, 20 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 240 shares at $522.49 on 19 August 2026, $125,397https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-20:796da84971Thu, 20 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,264 shares at $523.65 on 19 August 2026, $661,888https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-20:a727c3d0adThu, 20 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 441 shares at $524.51 on 19 August 2026, $231,309https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-20:b19eac18b7Thu, 20 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 895 shares at $525.60 on 19 August 2026, $470,409https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-20:3731dc522fThu, 20 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 2,105 shares at $526.76 on 19 August 2026, $1.1 millionhttps://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-20:72ed87aff9Thu, 20 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 2,135 shares at $527.58 on 19 August 2026, $1.1 millionhttps://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-20:3e863ddc58Thu, 20 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,200 shares at $528.59 on 19 August 2026, $634,305https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-20:c045031794Thu, 20 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 659 shares at $529.56 on 19 August 2026, $348,979https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-20:fef0d4c36fThu, 20 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 201 shares at $531.01 on 19 August 2026, $106,732https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-20:280ef086adThu, 20 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 80 shares at $531.62 on 19 August 2026, $42,530https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-20:405769e429Thu, 20 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 200 shares at $532.63 on 19 August 2026, $106,526https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-20:c944c7b55eThu, 20 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 80 shares at $535.22 on 19 August 2026, $42,817https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-20:905ab67bd2Thu, 20 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 239 shares at $509.48 on 18 August 2026, $121,767https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-19:52e0c49d48Wed, 19 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 231 shares at $510.47 on 18 August 2026, $117,919https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-19:36a7460e18Wed, 19 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 170 shares at $511.59 on 18 August 2026, $86,971https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-19:1ea3e45270Wed, 19 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 439 shares at $513.06 on 18 August 2026, $225,234https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-19:1f204b1379Wed, 19 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,264 shares at $514.18 on 18 August 2026, $649,918https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-19:e1632fcf9aWed, 19 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 2,333 shares at $514.99 on 18 August 2026, $1.2 millionhttps://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-19:3d9fdd0f26Wed, 19 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,880 shares at $516.04 on 18 August 2026, $970,164https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-19:b02454285fWed, 19 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 873 shares at $517.09 on 18 August 2026, $451,419https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-19:7b17484fc1Wed, 19 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,630 shares at $518.19 on 18 August 2026, $844,642https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-19:9c1d20eb3eWed, 19 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 441 shares at $518.65 on 18 August 2026, $228,724https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-19:ba00661627Wed, 19 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 213 shares at $501.06 on 17 August 2026, $106,726https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-18:5449ae84e8Tue, 18 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 427 shares at $502.18 on 17 August 2026, $214,431https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-18:45af99d6cfTue, 18 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 120 shares at $504.21 on 17 August 2026, $60,505https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-18:21754305e1Tue, 18 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,238 shares at $505.36 on 17 August 2026, $625,638https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-18:b4d56897fbTue, 18 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 2,521 shares at $506.35 on 17 August 2026, $1.3 millionhttps://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-18:d4b9b357c4Tue, 18 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 3,298 shares at $507.43 on 17 August 2026, $1.7 millionhttps://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-18:eac6468c85Tue, 18 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,683 shares at $508.17 on 17 August 2026, $855,254https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-18:6d58f65cf6Tue, 18 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 320 shares at $495.02 on 14 August 2026, $158,407https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-17:549d740f24Mon, 17 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 414 shares at $495.96 on 14 August 2026, $205,329https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-17:d26249a695Mon, 17 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 537 shares at $497.22 on 14 August 2026, $267,007https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-17:7c1dc0b07dMon, 17 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 2,130 shares at $498.39 on 14 August 2026, $1.1 millionhttps://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-17:74d083d506Mon, 17 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 3,630 shares at $499.30 on 14 August 2026, $1.8 millionhttps://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-17:c58a549401Mon, 17 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 2,148 shares at $500.05 on 14 August 2026, $1.1 millionhttps://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-17:e40f14bd09Mon, 17 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 321 shares at $500.93 on 14 August 2026, $160,797https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-17:cc7cdc59c8Mon, 17 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Schedule 13G/A filed by ROTHBLATT MARTINE A, 5.3% of the classhttps://greeksoup.ai/stocks/us/uthr/holders/us:UTHR:schedule-13:2026-08-14:7a025c65feFri, 14 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,253 shares at $500.08 on 13 August 2026, $626,598https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-14:c96d056d43Fri, 14 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,328 shares at $500.93 on 13 August 2026, $665,238https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-14:ff707d11b4Fri, 14 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,519 shares at $501.88 on 13 August 2026, $762,352https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-14:085ece2160Fri, 14 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 440 shares at $502.93 on 13 August 2026, $221,288https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-14:8104236297Fri, 14 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 160 shares at $503.83 on 13 August 2026, $80,612https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-14:8375d9e3adFri, 14 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 961 shares at $505.18 on 13 August 2026, $485,477https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-14:5c231ccaf0Fri, 14 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,679 shares at $506.16 on 13 August 2026, $849,845https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-14:01928f643eFri, 14 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 920 shares at $507.14 on 13 August 2026, $466,570https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-14:5aa477e8cfFri, 14 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 640 shares at $508.76 on 13 August 2026, $325,606https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-14:b3acba649bFri, 14 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 200 shares at $509.92 on 13 August 2026, $101,985https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-14:5dff60acfeFri, 14 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 160 shares at $511.12 on 13 August 2026, $81,779https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-14:6bf37c5637Fri, 14 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 240 shares at $512.36 on 13 August 2026, $122,966https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-14:c48ecd8aadFri, 14 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: short interest 2,112,367 shares at the 14 August 2026 settlement, 3.52 days to coverhttps://greeksoup.ai/stocks/us/uthr/short-interest/us:UTHR:short-interest:2026-08-14:75c29d646bFri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Schedule 13G/A filed by Wellington Management Group LLP, 3.2% of the classhttps://greeksoup.ai/stocks/us/uthr/holders/us:UTHR:schedule-13:2026-08-13:820199d150Thu, 13 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 40 shares at $507.08 on 12 August 2026, $20,283https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-13:4964615a88Thu, 13 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 440 shares at $508.86 on 12 August 2026, $223,898https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-13:104b101cd3Thu, 13 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 280 shares at $509.61 on 12 August 2026, $142,691https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-13:3532040987Thu, 13 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,152 shares at $511.12 on 12 August 2026, $588,808https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-13:62cf1d3724Thu, 13 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 542 shares at $511.75 on 12 August 2026, $277,367https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-13:571879f4caThu, 13 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,206 shares at $513.02 on 12 August 2026, $618,698https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-13:24079c5c2cThu, 13 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 558 shares at $514.18 on 12 August 2026, $286,915https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-13:5313581671Thu, 13 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 893 shares at $514.87 on 12 August 2026, $459,783https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-13:e865167c8eThu, 13 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 940 shares at $516.16 on 12 August 2026, $485,191https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-13:09e670a5c4Thu, 13 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 1,249 shares at $517.21 on 12 August 2026, $646,001https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-13:54174e9092Thu, 13 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> United Therapeutics Corp.: Rothblatt Martine A (Chairperson & CEO) sold 320 shares at $518.16 on 12 August 2026, $165,810https://greeksoup.ai/stocks/us/uthr/insiders/us:UTHR:insider:2026-08-13:76dbad1443Thu, 13 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]>